Evaluating the Relative Cost of a Targeted Design Versus an Untargeted Design for Randomized Clinical Trials

Drug Designing: Open Access
doi 10.4172/2169-0138.1000120
Full Text
Abstract

Available in full text

Date
Authors
Publisher

OMICS Publishing Group